Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,271

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026

Most affected stateHawaii 200 recalls mention this state

State: KS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 19, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall TerminatedTerminated: April 15, 2025Historical recordClass I

Polyvinyl Alcohol 1.4% Lubricating Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Dist. by: RUGBY LABORATORIES, Livonia, MI 48152, NDC 0536-1325-94.

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason: Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Published: November 29, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 8, 2025Historical recordClass II

Oxygen, Compressed USP, UN 1072, packaged in cylinders labeled as Size: a) C; b) D; c) E; d) H; e) M; f) M6, Rx only, Family Medical Supply, 2011 W Cumberland St. Dunn, NC 28334.

by Family Medical Supply Inc

Reason: cGMP Deviations
Published: November 22, 2023
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: December 4, 2023Historical recordClass II

GIVE AND GO PREPARED FOODS CORP

Product: Item 19858, Amazon Fresh, Frosted Mini Brownie with yellow a…
Reason: Potential plastic pieces in the product.
Published: November 22, 2023
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: February 25, 2026Historical recordClass I

TH Searcy LLC

Product: Guilt Free No Sugar Added Ice Cream Homemade Vanilla 1.5qts
Reason: Undeclared Egg
Published: November 22, 2023
Distribution: Wholesale to 3 distributors: Walmart, Kr…

View recall →

FDA Recall TerminatedTerminated: February 14, 2025Historical recordClass I

2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4903-11

by Pfizer Inc.

Reason: Presence of Particulate Matter: identified as glass.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 14, 2025Historical recordClass I

1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4904-11

by Pfizer Inc.

Reason: Presence of Particulate Matter: identified as glass.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 14, 2025Historical recordClass I

4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5mEq/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-5534-24

by Pfizer Inc.

Reason: Presence of Particulate Matter: identified as glass.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

Oxybutynin Chloride Extended-Release Tablet USP, 15 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-257-01.

by Zydus Pharmaceuticals (USA) Inc

Reason: Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

Oxybutynin Chloride Extended-Release Tablet USP, 10 mg, 100 count bottles Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-256-01.

by Zydus Pharmaceuticals (USA) Inc

Reason: Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

Oxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-255-01

by Zydus Pharmaceuticals (USA) Inc

Reason: Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-496-30

by Glenmark Pharmaceuticals Inc., USA

Reason: Failed Dissolution Specifications
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass III

Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11

by Zyla Life Sciences US Inc.

Reason: Sub-potent Drug: Lower potency than labeled.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 21, 2025Historical recordClass III

Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA, NDC#66689-307-08.

by VistaPharm LLC

Reason: Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur Dist - Dhar, Madhya Pradesh - 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-319-60.

by Glenmark Pharmaceuticals Inc., USA

Reason: Failed Dissolution Specifications: Out of specification for dissolution.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Clinical TREAT Antifungal Powder, Vanilla Scent, 3 OZ (85 g) tube, Active Ingredient: Miconazole Nitrate 2.0% w/w Antifungal, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093 USA, NDC: 53329-169-79

by MEDLINE INDUSTRIES, LP - Northfield

Reason: CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation for low assay results on the active ingredient miconazole nitrate.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 6, 2025Historical recordClass II

Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10

by Amneal Pharmaceuticals of New York, LLC

Reason: Failed Dissolution Specifications
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 27, 2024Historical recordClass III

Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada LGT 1C, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532. NDC 51672-3007-1

by Taro Pharmaceuticals Inc.

Reason: Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Buprenorphine HCl, Injection, 0.3mg/mL, For Intramuscular or Intravenous Use, Rx Only, 1mL Single Dose Vial, (supplied in packages of 5 vials) Distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC: 42023-179-05

by Par Sterile Products LLC

Reason: Crystallization; identified as Buprenorphine free base
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 9, 2024Historical recordClass II

Montelukast Sodium Tablets, USP 10 mg, Rx Only, 1000 count bottle, Distributed by: Dr. Reddy's Laboratories., Princeton, NJ 08540, Made in India, NDC# 55111-725-10.

by Dr. Reddy's Laboratories, Inc.

Reason: Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg.
Published: November 15, 2023
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: April 10, 2025Historical recordClass III

The Sausage Maker, Inc.

Product: The Sausage Maker Instacure #1
Reason: Contains Sodium Nitrite recalled for potential metal contamination
Published: November 15, 2023
Distribution: Nationwide

View recall →

Data last updated: October 19, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.